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Liver transplantation is the unique treatment for several end-stage
diseases.
Familial Amiloidotic Polineuropathy (FAP) is a neurodegenerative
disease related with systemic deposition of amyloidal fiber mainly on
peripheral nervous system, clinically translated by an autonomous
sensitive-motor neuropathy with severe functional limitations in some
cases. The unique treatment for FAP disease is a liver transplant with
a very aggressive medication to muscle metabolism and force
production(1).
To our knowledge there are no quantitative characterizations of body
composition, strength or functional capacity in this population
The purpose of this study was to compare levels of specific strength
(isometric strength adjusted by lean mass or muscle quality) and
functional capacity (meters in 6 minutes walk test) between FAP
patients after a liver transplant (4.1 2 months after transplant surgery)
(FAPTx) and a healthy group (HG).
•Isometric strength of quadriceps was measured
using an isokinetic dynamometer (Biodex) (2)
•Body composition was determined by measuring
lean mass of dominant lower extremity in a region
of interest (thigh) by dual-energy x-ray
absorptiometry (QDR-explorer – Hologic,
Waltham, MA; Fan bean mode) (3).
• Muscle quality was ascertained by taking the
ratio of strength to muscle mass (4).
• Functional capacity was determined by the
number of meters walked on 6MWT(5)
HG showed significant higher values than FAPTx patients for (table 1):
•Peak torque (66.3N 25.2N) vs 40.2N 17.6N respectively p=.000)
•Muscle quality (11.8 2.6 vs 7.9 2.7 respectively, p=.000
•Functional capacity (675.9 109.1m vs 511.4 139.1m respectively,
p=.000)
There are no differences between HG and FAPTx for (table 1):
• BMI (23.8 2.2 kg/m2 vs 22.0 3.8 kg/m2 respectively, p=.07)
•Thigh muscle mass (5.5kg 1.2kg vs 5.04kg 1.1kg respectively p=.14)
• FAPT patients have lower functional capacity, strength and
muscle quality than HG.
• The differences between groups for muscle quality and peak
torque but not thigh muscle mass seems highlight the
importance of the neural component of the disease and show
also the importance of training the process of force production
specially the sensoriomotor component in FAP patients and
probably the importance of a strengthening exercise program.
•Further studies are needed to explore training effects on
function after transplantation.
Sixty-four subjects where assigned in 2 groups: 46 patients FAPTx 
(27 males, 32±8 yrs and 19 females, 37±5 yrs) and eighteen HG (9 
males, 34±7 yrs and 9 female, 36±8 yrs).
Negative correlations were observed for FAPTx patients but not for
HG between age and peak torque (p=.013; r= -.363) and age and
thigh muscle mass (p=.011; r= -.373)(fig.1)
Table 1 – Body composition variables, strength, muscle quality and 
functional capacity (Mean sd; Min-Máx; p-value for t-test)
Fig 1- Scatterplot for correlations  between age and peak torque (A) and 
age and thigh muscle mass (B) for FAPTx group
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Mean±sd Min-Max Mean±sd Min-Max p-value
Age 34±7 23-59 35±7 21-46 0.681
Weight (kg) 62,9±12,5 35,6-101,2 65,6±9,0 54,1-79,7 0.406
Height (m) 1,69±0,08 1,53-1,85 1,66±0,08 1,53-1,80 0.185
Body Mass 
Index (kg/m2) 22,03±3,85 15,2-30,9 23,8±2,2 20,7-27,5 0.074
Functional 
Capacity (m) 511,43±139,12 163,5-708,9 675,85±109,08 525,7-971,2 0.000*
Peak Torque (N-
M) 40,22±17,65 10,0-94,5 66,31±25,21 35,20-122,70 0.000*
Total lean mass 
(kg) 45,41±8,08 28,23-66,38 45,9±9,08 33,36-60,53 0.834
% total fat mass 22,50±9,23 9,70-42,3 26,62±7,96 11,82-39,42 0.102
Thigh muscle 
mass (kg) 5,04±1,11 2,61-8,18 5,52±1,23 3,92-7,56 0.138
muscle quality 7,92±2,74 3,84-14,99 11,77±2,61 8,03-16,24 0.000*
Variables
Group FAPTx (n=46) Group HG (n=18)
* Differences between the means of both groups (p<0,05)
 
 
